id	sid	tid	token	lemma	pos
cord-342324-it6zcyht	1	1	key	key	JJ
cord-342324-it6zcyht	1	2	:	:	:
cord-342324-it6zcyht	1	3	cord-342324-it6zcyht	cord-342324-it6zcyht	CD
cord-342324-it6zcyht	1	4	authors	author	NNS
cord-342324-it6zcyht	1	5	:	:	:
cord-342324-it6zcyht	1	6	Dhaliwal	Dhaliwal	NNP
cord-342324-it6zcyht	1	7	,	,	,
cord-342324-it6zcyht	1	8	Ruban	Ruban	NNP
cord-342324-it6zcyht	1	9	;	;	:
cord-342324-it6zcyht	1	10	Bhadada	Bhadada	NNP
cord-342324-it6zcyht	1	11	,	,	,
cord-342324-it6zcyht	1	12	Sanjay	Sanjay	NNP
cord-342324-it6zcyht	1	13	K	K	NNP
cord-342324-it6zcyht	1	14	;	;	:
cord-342324-it6zcyht	1	15	Rao	Rao	NNP
cord-342324-it6zcyht	1	16	,	,	,
cord-342324-it6zcyht	1	17	Sudhaker	Sudhaker	NNP
cord-342324-it6zcyht	1	18	D	D	NNP
cord-342324-it6zcyht	1	19	title	title	NN
cord-342324-it6zcyht	1	20	:	:	:
cord-342324-it6zcyht	1	21	Letter	letter	NN
cord-342324-it6zcyht	1	22	to	to	IN
cord-342324-it6zcyht	1	23	the	the	DT
cord-342324-it6zcyht	1	24	Editor	editor	NN
cord-342324-it6zcyht	1	25	:	:	:
cord-342324-it6zcyht	1	26	“	"	``
cord-342324-it6zcyht	1	27	Our	-PRON-	PRP$
cord-342324-it6zcyht	1	28	Response	response	NN
cord-342324-it6zcyht	1	29	to	to	TO
cord-342324-it6zcyht	1	30	COVID-19	covid-19	VB
cord-342324-it6zcyht	1	31	as	as	IN
cord-342324-it6zcyht	1	32	Endocrinologists	endocrinologist	NNS
cord-342324-it6zcyht	1	33	and	and	CC
cord-342324-it6zcyht	1	34	Diabetologists	Diabetologists	NNPS
cord-342324-it6zcyht	1	35	”	"	''
cord-342324-it6zcyht	1	36	date	date	NN
cord-342324-it6zcyht	1	37	:	:	:
cord-342324-it6zcyht	1	38	2020	2020	CD
cord-342324-it6zcyht	1	39	-	-	HYPH
cord-342324-it6zcyht	1	40	05	05	CD
cord-342324-it6zcyht	1	41	-	-	HYPH
cord-342324-it6zcyht	1	42	08	08	CD
cord-342324-it6zcyht	1	43	journal	journal	NN
cord-342324-it6zcyht	1	44	:	:	:
cord-342324-it6zcyht	1	45	J	J	NNP
cord-342324-it6zcyht	1	46	Clin	Clin	NNP
cord-342324-it6zcyht	1	47	Endocrinol	Endocrinol	NNP
cord-342324-it6zcyht	1	48	Metab	Metab	NNP
cord-342324-it6zcyht	1	49	DOI	doi	NN
cord-342324-it6zcyht	1	50	:	:	:
cord-342324-it6zcyht	2	1	10.1210	10.1210	NNP
cord-342324-it6zcyht	2	2	/	/	SYM
cord-342324-it6zcyht	2	3	clinem	clinem	NNP
cord-342324-it6zcyht	2	4	/	/	SYM
cord-342324-it6zcyht	2	5	dgaa254	dgaa254	NNP
cord-342324-it6zcyht	2	6	sha	sha	NNP
cord-342324-it6zcyht	2	7	:	:	:
cord-342324-it6zcyht	2	8	70b05d31dd0f05b5a75de5c45627a1969a3d0161	70b05d31dd0f05b5a75de5c45627a1969a3d0161	CD
cord-342324-it6zcyht	2	9	doc_id	doc_id	CD
cord-342324-it6zcyht	2	10	:	:	:
cord-342324-it6zcyht	2	11	342324	342324	CD
cord-342324-it6zcyht	2	12	cord_uid	cord_uid	NNS
cord-342324-it6zcyht	2	13	:	:	:
cord-342324-it6zcyht	2	14	it6zcyht	it6zcyht	.
cord-342324-it6zcyht	3	1	nan	nan	NNP
cord-342324-it6zcyht	4	1	A	a	DT
cord-342324-it6zcyht	5	1	c	c	NNP
cord-342324-it6zcyht	5	2	c	c	NN
cord-342324-it6zcyht	5	3	e	e	NN
cord-342324-it6zcyht	5	4	p	p	NN
cord-342324-it6zcyht	6	1	t	t	NNP
cord-342324-it6zcyht	6	2	e	e	NNP
cord-342324-it6zcyht	6	3	d	d	NNP
cord-342324-it6zcyht	6	4	M	M	NNP
cord-342324-it6zcyht	6	5	a	a	NNP
cord-342324-it6zcyht	7	1	n	n	CC
cord-342324-it6zcyht	7	2	u	u	NNP
cord-342324-it6zcyht	7	3	s	s	NNP
cord-342324-it6zcyht	7	4	c	c	NN
cord-342324-it6zcyht	7	5	r	r	NN
cord-342324-it6zcyht	8	1	i	i	NN
cord-342324-it6zcyht	8	2	p	p	NN
cord-342324-it6zcyht	8	3	t	t	NN
cord-342324-it6zcyht	9	1	We	-PRON-	PRP
cord-342324-it6zcyht	9	2	read	read	VBP
cord-342324-it6zcyht	9	3	with	with	IN
cord-342324-it6zcyht	9	4	great	great	JJ
cord-342324-it6zcyht	9	5	interest	interest	NN
cord-342324-it6zcyht	9	6	the	the	DT
cord-342324-it6zcyht	9	7	timely	timely	JJ
cord-342324-it6zcyht	9	8	and	and	CC
cord-342324-it6zcyht	9	9	informative	informative	JJ
cord-342324-it6zcyht	9	10	editorial	editorial	NN
cord-342324-it6zcyht	9	11	by	by	IN
cord-342324-it6zcyht	9	12	Kaiser	Kaiser	NNP
cord-342324-it6zcyht	9	13	et	et	NNP
cord-342324-it6zcyht	9	14	al	al	NNP
cord-342324-it6zcyht	9	15	on	on	IN
cord-342324-it6zcyht	9	16	managing	manage	VBG
cord-342324-it6zcyht	9	17	certain	certain	JJ
cord-342324-it6zcyht	9	18	endocrine	endocrine	JJ
cord-342324-it6zcyht	9	19	conditions	condition	NNS
cord-342324-it6zcyht	9	20	during	during	IN
cord-342324-it6zcyht	9	21	COVID-19	covid-19	CD
cord-342324-it6zcyht	9	22	pandemic	pandemic	NN
cord-342324-it6zcyht	9	23	(	(	-LRB-
cord-342324-it6zcyht	9	24	1	1	CD
cord-342324-it6zcyht	9	25	)	)	-RRB-
cord-342324-it6zcyht	9	26	.	.	.
cord-342324-it6zcyht	10	1	However	however	RB
cord-342324-it6zcyht	10	2	,	,	,
cord-342324-it6zcyht	10	3	couple	couple	NN
cord-342324-it6zcyht	10	4	of	of	IN
cord-342324-it6zcyht	10	5	equally	equally	RB
cord-342324-it6zcyht	10	6	important	important	JJ
cord-342324-it6zcyht	10	7	areas	area	NNS
cord-342324-it6zcyht	10	8	of	of	IN
cord-342324-it6zcyht	10	9	concern	concern	NN
cord-342324-it6zcyht	10	10	were	be	VBD
cord-342324-it6zcyht	10	11	not	not	RB
cord-342324-it6zcyht	10	12	mentioned	mention	VBN
cord-342324-it6zcyht	10	13	.	.	.
cord-342324-it6zcyht	11	1	First	first	RB
cord-342324-it6zcyht	11	2	,	,	,
cord-342324-it6zcyht	11	3	the	the	DT
cord-342324-it6zcyht	11	4	management	management	NN
cord-342324-it6zcyht	11	5	of	of	IN
cord-342324-it6zcyht	11	6	hypoparathyroidism	hypoparathyroidism	NNP
cord-342324-it6zcyht	11	7	,	,	,
cord-342324-it6zcyht	11	8	particularly	particularly	RB
cord-342324-it6zcyht	11	9	in	in	IN
cord-342324-it6zcyht	11	10	light	light	NN
cord-342324-it6zcyht	11	11	of	of	IN
cord-342324-it6zcyht	11	12	recalled	recall	VBN
cord-342324-it6zcyht	11	13	recombinant	recombinant	JJ
cord-342324-it6zcyht	11	14	human	human	JJ
cord-342324-it6zcyht	11	15	parathyroid	parathyroid	NN
cord-342324-it6zcyht	11	16	hormone	hormone	NN
cord-342324-it6zcyht	11	17	,	,	,
cord-342324-it6zcyht	11	18	deserves	deserve	VBZ
cord-342324-it6zcyht	11	19	some	some	DT
cord-342324-it6zcyht	11	20	attention	attention	NN
cord-342324-it6zcyht	11	21	.	.	.
cord-342324-it6zcyht	12	1	Patients	patient	NNS
cord-342324-it6zcyht	12	2	with	with	IN
cord-342324-it6zcyht	12	3	symptomatic	symptomatic	JJ
cord-342324-it6zcyht	12	4	COVID-19	covid-19	JJ
cord-342324-it6zcyht	12	5	infection	infection	NN
cord-342324-it6zcyht	12	6	manifest	manifest	VBP
cord-342324-it6zcyht	12	7	several	several	JJ
cord-342324-it6zcyht	12	8	electrolyte	electrolyte	JJ
cord-342324-it6zcyht	12	9	abnormalities	abnormality	NNS
cord-342324-it6zcyht	12	10	including	include	VBG
cord-342324-it6zcyht	12	11	serum	serum	NN
cord-342324-it6zcyht	12	12	calcium	calcium	NN
cord-342324-it6zcyht	12	13	.	.	.
cord-342324-it6zcyht	13	1	Hypoparathyroid	hypoparathyroid	JJ
cord-342324-it6zcyht	13	2	patients	patient	NNS
cord-342324-it6zcyht	13	3	can	can	MD
cord-342324-it6zcyht	13	4	be	be	VB
cord-342324-it6zcyht	13	5	at	at	IN
cord-342324-it6zcyht	13	6	risk	risk	NN
cord-342324-it6zcyht	13	7	of	of	IN
cord-342324-it6zcyht	13	8	sudden	sudden	JJ
cord-342324-it6zcyht	13	9	drop	drop	NN
cord-342324-it6zcyht	13	10	in	in	IN
cord-342324-it6zcyht	13	11	serum	serum	NN
cord-342324-it6zcyht	13	12	calcium	calcium	NN
cord-342324-it6zcyht	13	13	level	level	NN
cord-342324-it6zcyht	13	14	after	after	IN
cord-342324-it6zcyht	13	15	missing	miss	VBG
cord-342324-it6zcyht	13	16	only	only	RB
cord-342324-it6zcyht	13	17	a	a	DT
cord-342324-it6zcyht	13	18	few	few	JJ
cord-342324-it6zcyht	13	19	doses	dose	NNS
cord-342324-it6zcyht	13	20	of	of	IN
cord-342324-it6zcyht	13	21	calcitriol	calcitriol	NN
cord-342324-it6zcyht	13	22	and	and	CC
cord-342324-it6zcyht	13	23	calcium	calcium	NN
cord-342324-it6zcyht	13	24	,	,	,
cord-342324-it6zcyht	13	25	and	and	CC
cord-342324-it6zcyht	13	26	may	may	MD
cord-342324-it6zcyht	13	27	develop	develop	VB
cord-342324-it6zcyht	13	28	tetany	tetany	NN
cord-342324-it6zcyht	13	29	,	,	,
cord-342324-it6zcyht	13	30	laryngeal	laryngeal	NN
cord-342324-it6zcyht	13	31	spasm	spasm	NN
cord-342324-it6zcyht	13	32	,	,	,
cord-342324-it6zcyht	13	33	and	and	CC
cord-342324-it6zcyht	13	34	seizures	seizure	NNS
cord-342324-it6zcyht	13	35	.	.	.
cord-342324-it6zcyht	14	1	The	the	DT
cord-342324-it6zcyht	14	2	only	only	JJ
cord-342324-it6zcyht	14	3	recourse	recourse	NN
cord-342324-it6zcyht	14	4	in	in	RB
cord-342324-it6zcyht	14	5	during	during	IN
cord-342324-it6zcyht	14	6	COVID-19	covid-19	JJ
cord-342324-it6zcyht	14	7	pandemic	pandemic	NN
cord-342324-it6zcyht	14	8	is	be	VBZ
cord-342324-it6zcyht	14	9	to	to	TO
cord-342324-it6zcyht	14	10	administer	administer	VB
cord-342324-it6zcyht	14	11	intravenous	intravenous	JJ
cord-342324-it6zcyht	14	12	calcium	calcium	NN
cord-342324-it6zcyht	14	13	in	in	IN
cord-342324-it6zcyht	14	14	an	an	DT
cord-342324-it6zcyht	14	15	emergency	emergency	NN
cord-342324-it6zcyht	14	16	room	room	NN
cord-342324-it6zcyht	14	17	,	,	,
cord-342324-it6zcyht	14	18	which	which	WDT
cord-342324-it6zcyht	14	19	should	should	MD
cord-342324-it6zcyht	14	20	be	be	VB
cord-342324-it6zcyht	14	21	avoided	avoid	VBN
cord-342324-it6zcyht	14	22	during	during	IN
cord-342324-it6zcyht	14	23	a	a	DT
cord-342324-it6zcyht	14	24	pandemic	pandemic	NN
cord-342324-it6zcyht	14	25	for	for	IN
cord-342324-it6zcyht	14	26	obvious	obvious	JJ
cord-342324-it6zcyht	14	27	reasons	reason	NNS
cord-342324-it6zcyht	14	28	.	.	.
cord-342324-it6zcyht	15	1	In	in	IN
cord-342324-it6zcyht	15	2	addition	addition	NN
cord-342324-it6zcyht	15	3	,	,	,
cord-342324-it6zcyht	15	4	clinicians	clinician	NNS
cord-342324-it6zcyht	15	5	should	should	MD
cord-342324-it6zcyht	15	6	be	be	VB
cord-342324-it6zcyht	15	7	aware	aware	JJ
cord-342324-it6zcyht	15	8	of	of	IN
cord-342324-it6zcyht	15	9	ECG	ECG	NNP
cord-342324-it6zcyht	15	10	abnormalities	abnormality	NNS
cord-342324-it6zcyht	15	11	if	if	IN
cord-342324-it6zcyht	15	12	the	the	DT
cord-342324-it6zcyht	15	13	patients	patient	NNS
cord-342324-it6zcyht	15	14	are	be	VBP
cord-342324-it6zcyht	15	15	being	be	VBG
cord-342324-it6zcyht	15	16	treated	treat	VBN
cord-342324-it6zcyht	15	17	with	with	IN
cord-342324-it6zcyht	15	18	chloroquine	chloroquine	NN
cord-342324-it6zcyht	15	19	,	,	,
cord-342324-it6zcyht	15	20	hydroxychloroquine	hydroxychloroquine	NN
cord-342324-it6zcyht	15	21	or	or	CC
cord-342324-it6zcyht	15	22	azithromycin	azithromycin	NNP
cord-342324-it6zcyht	15	23	,	,	,
cord-342324-it6zcyht	15	24	all	all	DT
cord-342324-it6zcyht	15	25	which	which	WDT
cord-342324-it6zcyht	15	26	are	be	VBP
cord-342324-it6zcyht	15	27	known	know	VBN
cord-342324-it6zcyht	15	28	to	to	TO
cord-342324-it6zcyht	15	29	cause	cause	VB
cord-342324-it6zcyht	15	30	prolonged	prolong	VBN
cord-342324-it6zcyht	15	31	QTc	QTc	NNP
cord-342324-it6zcyht	15	32	interval	interval	NN
cord-342324-it6zcyht	15	33	(	(	-LRB-
cord-342324-it6zcyht	15	34	2	2	CD
cord-342324-it6zcyht	15	35	)	)	-RRB-
cord-342324-it6zcyht	15	36	,	,	,
cord-342324-it6zcyht	15	37	as	as	IN
cord-342324-it6zcyht	15	38	does	do	VBZ
cord-342324-it6zcyht	15	39	acute	acute	JJ
cord-342324-it6zcyht	15	40	and	and	CC
cord-342324-it6zcyht	15	41	severe	severe	JJ
cord-342324-it6zcyht	15	42	hypocalcemia	hypocalcemia	NN
cord-342324-it6zcyht	15	43	(	(	-LRB-
cord-342324-it6zcyht	15	44	3	3	CD
cord-342324-it6zcyht	15	45	)	)	-RRB-
cord-342324-it6zcyht	15	46	.	.	.
cord-342324-it6zcyht	16	1	Thus	thus	RB
cord-342324-it6zcyht	16	2	,	,	,
cord-342324-it6zcyht	16	3	there	there	EX
cord-342324-it6zcyht	16	4	is	be	VBZ
cord-342324-it6zcyht	16	5	a	a	DT
cord-342324-it6zcyht	16	6	need	need	NN
cord-342324-it6zcyht	16	7	for	for	IN
cord-342324-it6zcyht	16	8	close	close	JJ
cord-342324-it6zcyht	16	9	monitoring	monitoring	NN
cord-342324-it6zcyht	16	10	of	of	IN
cord-342324-it6zcyht	16	11	serum	serum	NN
cord-342324-it6zcyht	16	12	calcium	calcium	NN
cord-342324-it6zcyht	16	13	levels	level	NNS
cord-342324-it6zcyht	16	14	in	in	IN
cord-342324-it6zcyht	16	15	symptomatic	symptomatic	JJ
cord-342324-it6zcyht	16	16	COVID	covid	JJ
cord-342324-it6zcyht	16	17	patients	patient	NNS
cord-342324-it6zcyht	16	18	,	,	,
cord-342324-it6zcyht	16	19	and	and	CC
cord-342324-it6zcyht	16	20	adherence	adherence	NN
cord-342324-it6zcyht	16	21	with	with	IN
cord-342324-it6zcyht	16	22	calcitriol	calcitriol	NN
cord-342324-it6zcyht	16	23	and	and	CC
cord-342324-it6zcyht	16	24	calcium	calcium	NN
cord-342324-it6zcyht	16	25	supplements	supplement	NNS
cord-342324-it6zcyht	16	26	as	as	IN
cord-342324-it6zcyht	16	27	prescribed	prescribe	VBN
cord-342324-it6zcyht	16	28	and	and	CC
cord-342324-it6zcyht	16	29	follow	follow	VB
cord-342324-it6zcyht	16	30	sick	sick	JJ
cord-342324-it6zcyht	16	31	-	-	HYPH
cord-342324-it6zcyht	16	32	day	day	NN
cord-342324-it6zcyht	16	33	guidelines	guideline	NNS
cord-342324-it6zcyht	16	34	(	(	-LRB-
cord-342324-it6zcyht	16	35	4	4	CD
cord-342324-it6zcyht	16	36	)	)	-RRB-
cord-342324-it6zcyht	16	37	.	.	.
cord-342324-it6zcyht	17	1	Second	second	JJ
cord-342324-it6zcyht	17	2	area	area	NN
cord-342324-it6zcyht	17	3	of	of	IN
cord-342324-it6zcyht	17	4	concern	concern	NN
cord-342324-it6zcyht	17	5	is	be	VBZ
cord-342324-it6zcyht	17	6	the	the	DT
cord-342324-it6zcyht	17	7	potential	potential	NN
cord-342324-it6zcyht	17	8	for	for	IN
cord-342324-it6zcyht	17	9	interruption	interruption	NN
cord-342324-it6zcyht	17	10	of	of	IN
cord-342324-it6zcyht	17	11	parenteral	parenteral	JJ
cord-342324-it6zcyht	17	12	treatments	treatment	NNS
cord-342324-it6zcyht	17	13	in	in	IN
cord-342324-it6zcyht	17	14	patients	patient	NNS
cord-342324-it6zcyht	17	15	with	with	IN
cord-342324-it6zcyht	17	16	osteoporosis	osteoporosis	NN
cord-342324-it6zcyht	17	17	during	during	IN
cord-342324-it6zcyht	17	18	this	this	DT
cord-342324-it6zcyht	17	19	pandemic	pandemic	NN
cord-342324-it6zcyht	17	20	,	,	,
cord-342324-it6zcyht	17	21	many	many	DT
cord-342324-it6zcyht	17	22	of	of	IN
cord-342324-it6zcyht	17	23	whom	whom	WP
cord-342324-it6zcyht	17	24	are	be	VBP
cord-342324-it6zcyht	17	25	in	in	IN
cord-342324-it6zcyht	17	26	the	the	DT
cord-342324-it6zcyht	17	27	high	high	JJ
cord-342324-it6zcyht	17	28	-	-	HYPH
cord-342324-it6zcyht	17	29	risk	risk	NN
cord-342324-it6zcyht	17	30	group	group	NN
cord-342324-it6zcyht	17	31	for	for	IN
cord-342324-it6zcyht	17	32	COVID-19	covid-19	JJ
cord-342324-it6zcyht	17	33	infection	infection	NN
cord-342324-it6zcyht	17	34	because	because	IN
cord-342324-it6zcyht	17	35	of	of	IN
cord-342324-it6zcyht	17	36	advanced	advanced	JJ
cord-342324-it6zcyht	17	37	age	age	NN
cord-342324-it6zcyht	17	38	and/or	and/or	CC
cord-342324-it6zcyht	17	39	comorbidities	comorbiditie	NNS
cord-342324-it6zcyht	17	40	.	.	.
cord-342324-it6zcyht	18	1	The	the	DT
cord-342324-it6zcyht	18	2	spread	spread	NN
cord-342324-it6zcyht	18	3	of	of	IN
cord-342324-it6zcyht	18	4	COVID-19	covid-19	JJ
cord-342324-it6zcyht	18	5	infection	infection	NN
cord-342324-it6zcyht	18	6	leading	lead	VBG
cord-342324-it6zcyht	18	7	to	to	IN
cord-342324-it6zcyht	18	8	limited	limited	JJ
cord-342324-it6zcyht	18	9	or	or	CC
cord-342324-it6zcyht	18	10	no	no	DT
cord-342324-it6zcyht	18	11	access	access	NN
cord-342324-it6zcyht	18	12	to	to	IN
cord-342324-it6zcyht	18	13	clinics	clinic	NNS
cord-342324-it6zcyht	18	14	or	or	CC
cord-342324-it6zcyht	18	15	infusion	infusion	NN
cord-342324-it6zcyht	18	16	centers	center	NNS
cord-342324-it6zcyht	18	17	may	may	MD
cord-342324-it6zcyht	18	18	result	result	VB
cord-342324-it6zcyht	18	19	in	in	IN
cord-342324-it6zcyht	18	20	missing	miss	VBG
cord-342324-it6zcyht	18	21	scheduled	schedule	VBN
cord-342324-it6zcyht	18	22	time	time	NN
cord-342324-it6zcyht	18	23	-	-	HYPH
cord-342324-it6zcyht	18	24	sensitive	sensitive	JJ
cord-342324-it6zcyht	18	25	parenteral	parenteral	JJ
cord-342324-it6zcyht	18	26	medications	medication	NNS
cord-342324-it6zcyht	18	27	.	.	.
cord-342324-it6zcyht	19	1	While	while	IN
cord-342324-it6zcyht	19	2	administration	administration	NN
cord-342324-it6zcyht	19	3	of	of	IN
cord-342324-it6zcyht	19	4	intravenous	intravenous	NNP
cord-342324-it6zcyht	19	5	zoledronic	zoledronic	NNP
cord-342324-it6zcyht	19	6	acid	acid	NN
cord-342324-it6zcyht	19	7	can	can	MD
cord-342324-it6zcyht	19	8	be	be	VB
cord-342324-it6zcyht	19	9	delayed	delay	VBN
cord-342324-it6zcyht	19	10	for	for	IN
cord-342324-it6zcyht	19	11	a	a	DT
cord-342324-it6zcyht	19	12	few	few	JJ
cord-342324-it6zcyht	19	13	months	month	NNS
cord-342324-it6zcyht	19	14	to	to	IN
cord-342324-it6zcyht	19	15	a	a	DT
cord-342324-it6zcyht	19	16	year	year	NN
cord-342324-it6zcyht	19	17	,	,	,
cord-342324-it6zcyht	19	18	such	such	JJ
cord-342324-it6zcyht	19	19	time	time	NN
cord-342324-it6zcyht	19	20	-	-	HYPH
cord-342324-it6zcyht	19	21	lapse	lapse	NN
cord-342324-it6zcyht	19	22	latitude	latitude	NN
cord-342324-it6zcyht	19	23	does	do	VBZ
cord-342324-it6zcyht	19	24	not	not	RB
cord-342324-it6zcyht	19	25	apply	apply	VB
cord-342324-it6zcyht	19	26	to	to	IN
cord-342324-it6zcyht	19	27	subcutaneous	subcutaneous	JJ
cord-342324-it6zcyht	19	28	denosumab	denosumab	NNS
cord-342324-it6zcyht	19	29	because	because	IN
cord-342324-it6zcyht	19	30	of	of	IN
cord-342324-it6zcyht	19	31	the	the	DT
cord-342324-it6zcyht	19	32	potential	potential	NN
cord-342324-it6zcyht	19	33	for	for	IN
cord-342324-it6zcyht	19	34	the	the	DT
cord-342324-it6zcyht	19	35	so	so	RB
cord-342324-it6zcyht	19	36	-	-	HYPH
cord-342324-it6zcyht	19	37	called	call	VBN
cord-342324-it6zcyht	19	38	"	"	``
cord-342324-it6zcyht	19	39	rebound	rebound	NN
cord-342324-it6zcyht	19	40	fractures	fracture	NNS
cord-342324-it6zcyht	19	41	"	"	''
cord-342324-it6zcyht	19	42	(	(	-LRB-
cord-342324-it6zcyht	19	43	5	5	CD
cord-342324-it6zcyht	19	44	)	)	-RRB-
cord-342324-it6zcyht	19	45	,	,	,
cord-342324-it6zcyht	19	46	although	although	IN
cord-342324-it6zcyht	19	47	there	there	EX
cord-342324-it6zcyht	19	48	is	be	VBZ
cord-342324-it6zcyht	19	49	no	no	DT
cord-342324-it6zcyht	19	50	consensus	consensus	NN
cord-342324-it6zcyht	19	51	on	on	IN
cord-342324-it6zcyht	19	52	this	this	DT
cord-342324-it6zcyht	19	53	complication	complication	NN
cord-342324-it6zcyht	19	54	(	(	-LRB-
cord-342324-it6zcyht	19	55	6	6	CD
cord-342324-it6zcyht	19	56	)	)	-RRB-
cord-342324-it6zcyht	19	57	.	.	.
cord-342324-it6zcyht	20	1	Nevertheless	nevertheless	RB
cord-342324-it6zcyht	20	2	,	,	,
cord-342324-it6zcyht	20	3	it	-PRON-	PRP
cord-342324-it6zcyht	20	4	is	be	VBZ
cord-342324-it6zcyht	20	5	important	important	JJ
cord-342324-it6zcyht	20	6	not	not	RB
cord-342324-it6zcyht	20	7	to	to	TO
cord-342324-it6zcyht	20	8	delay	delay	VB
cord-342324-it6zcyht	20	9	the	the	DT
cord-342324-it6zcyht	20	10	scheduled	schedule	VBN
cord-342324-it6zcyht	20	11	denosumab	denosumab	NNS
cord-342324-it6zcyht	20	12	dose	dose	VB
cord-342324-it6zcyht	20	13	by	by	IN
cord-342324-it6zcyht	20	14	more	more	JJR
cord-342324-it6zcyht	20	15	than	than	IN
cord-342324-it6zcyht	20	16	4	4	CD
cord-342324-it6zcyht	20	17	-	-	SYM
cord-342324-it6zcyht	20	18	6	6	CD
cord-342324-it6zcyht	20	19	weeks	week	NNS
cord-342324-it6zcyht	20	20	.	.	.
cord-342324-it6zcyht	21	1	Clinics	clinic	NNS
cord-342324-it6zcyht	21	2	could	could	MD
cord-342324-it6zcyht	21	3	accommodate	accommodate	VB
cord-342324-it6zcyht	21	4	the	the	DT
cord-342324-it6zcyht	21	5	visits	visit	NNS
cord-342324-it6zcyht	21	6	for	for	IN
cord-342324-it6zcyht	21	7	administration	administration	NN
cord-342324-it6zcyht	21	8	of	of	IN
cord-342324-it6zcyht	21	9	injectable	injectable	JJ
cord-342324-it6zcyht	21	10	medications	medication	NNS
cord-342324-it6zcyht	21	11	by	by	IN
cord-342324-it6zcyht	21	12	taking	take	VBG
cord-342324-it6zcyht	21	13	necessary	necessary	JJ
cord-342324-it6zcyht	21	14	A	a	NN
cord-342324-it6zcyht	21	15	c	c	NN
cord-342324-it6zcyht	21	16	c	c	NN
cord-342324-it6zcyht	21	17	e	e	NN
cord-342324-it6zcyht	21	18	p	p	NN
cord-342324-it6zcyht	21	19	t	t	NN
cord-342324-it6zcyht	21	20	e	e	NN
cord-342324-it6zcyht	21	21	d	d	NNP
cord-342324-it6zcyht	21	22	M	M	NNP
cord-342324-it6zcyht	21	23	a	a	NNP
cord-342324-it6zcyht	22	1	n	n	CC
cord-342324-it6zcyht	22	2	u	u	NNP
cord-342324-it6zcyht	22	3	s	s	NNP
cord-342324-it6zcyht	22	4	c	c	NN
cord-342324-it6zcyht	22	5	r	r	NN
cord-342324-it6zcyht	23	1	i	i	NN
cord-342324-it6zcyht	23	2	p	p	NN
cord-342324-it6zcyht	23	3	t	t	NN
cord-342324-it6zcyht	23	4	precautions	precaution	NNS
cord-342324-it6zcyht	23	5	to	to	TO
cord-342324-it6zcyht	23	6	ensure	ensure	VB
cord-342324-it6zcyht	23	7	the	the	DT
cord-342324-it6zcyht	23	8	health	health	NN
cord-342324-it6zcyht	23	9	and	and	CC
cord-342324-it6zcyht	23	10	safety	safety	NN
cord-342324-it6zcyht	23	11	of	of	IN
cord-342324-it6zcyht	23	12	the	the	DT
cord-342324-it6zcyht	23	13	patients	patient	NNS
cord-342324-it6zcyht	23	14	or	or	CC
cord-342324-it6zcyht	23	15	temporarily	temporarily	RB
cord-342324-it6zcyht	23	16	switch	switch	VB
cord-342324-it6zcyht	23	17	treatment	treatment	NN
cord-342324-it6zcyht	23	18	to	to	IN
cord-342324-it6zcyht	23	19	an	an	DT
cord-342324-it6zcyht	23	20	oral	oral	JJ
cord-342324-it6zcyht	23	21	bisphosphonate	bisphosphonate	NN
cord-342324-it6zcyht	23	22	.	.	.
cord-342324-it6zcyht	24	1	Another	another	DT
cord-342324-it6zcyht	24	2	option	option	NN
cord-342324-it6zcyht	24	3	is	be	VBZ
cord-342324-it6zcyht	24	4	to	to	IN
cord-342324-it6zcyht	24	5	self	self	NN
cord-342324-it6zcyht	24	6	-	-	HYPH
cord-342324-it6zcyht	24	7	administer	administer	VB
cord-342324-it6zcyht	24	8	denosumab	denosumab	NNS
cord-342324-it6zcyht	24	9	if	if	IN
cord-342324-it6zcyht	24	10	the	the	DT
cord-342324-it6zcyht	24	11	patient	patient	NN
cord-342324-it6zcyht	24	12	is	be	VBZ
cord-342324-it6zcyht	24	13	reluctant	reluctant	JJ
cord-342324-it6zcyht	24	14	to	to	TO
cord-342324-it6zcyht	24	15	go	go	VB
cord-342324-it6zcyht	24	16	to	to	IN
cord-342324-it6zcyht	24	17	the	the	DT
cord-342324-it6zcyht	24	18	clinic	clinic	NN
cord-342324-it6zcyht	24	19	.	.	.
cord-342324-it6zcyht	25	1	Amgen	Amgen	NNP
cord-342324-it6zcyht	25	2	,	,	,
cord-342324-it6zcyht	25	3	the	the	DT
cord-342324-it6zcyht	25	4	manufacturer	manufacturer	NN
cord-342324-it6zcyht	25	5	of	of	IN
cord-342324-it6zcyht	25	6	denosumab	denosumab	NNP
cord-342324-it6zcyht	25	7	,	,	,
cord-342324-it6zcyht	25	8	may	may	MD
cord-342324-it6zcyht	25	9	have	have	VB
cord-342324-it6zcyht	25	10	resources	resource	NNS
cord-342324-it6zcyht	25	11	available	available	JJ
cord-342324-it6zcyht	25	12	to	to	TO
cord-342324-it6zcyht	25	13	help	help	VB
cord-342324-it6zcyht	25	14	patients	patient	NNS
cord-342324-it6zcyht	25	15	with	with	IN
cord-342324-it6zcyht	25	16	self	self	NN
cord-342324-it6zcyht	25	17	-	-	HYPH
cord-342324-it6zcyht	25	18	administration	administration	NN
cord-342324-it6zcyht	25	19	.	.	.
cord-342324-it6zcyht	26	1	Also	also	RB
cord-342324-it6zcyht	26	2	,	,	,
cord-342324-it6zcyht	26	3	since	since	IN
cord-342324-it6zcyht	26	4	there	there	EX
cord-342324-it6zcyht	26	5	is	be	VBZ
cord-342324-it6zcyht	26	6	an	an	DT
cord-342324-it6zcyht	26	7	increased	increased	JJ
cord-342324-it6zcyht	26	8	risk	risk	NN
cord-342324-it6zcyht	26	9	of	of	IN
cord-342324-it6zcyht	26	10	thromboembolic	thromboembolic	JJ
cord-342324-it6zcyht	26	11	events	event	NNS
cord-342324-it6zcyht	26	12	related	relate	VBN
cord-342324-it6zcyht	26	13	to	to	IN
cord-342324-it6zcyht	26	14	COVID-19	covid-19	JJ
cord-342324-it6zcyht	26	15	infection	infection	NN
cord-342324-it6zcyht	26	16	(	(	-LRB-
cord-342324-it6zcyht	26	17	7	7	CD
cord-342324-it6zcyht	26	18	)	)	-RRB-
cord-342324-it6zcyht	26	19	,	,	,
cord-342324-it6zcyht	26	20	it	-PRON-	PRP
cord-342324-it6zcyht	26	21	is	be	VBZ
cord-342324-it6zcyht	26	22	best	good	JJS
cord-342324-it6zcyht	26	23	to	to	TO
cord-342324-it6zcyht	26	24	discontinue	discontinue	VB
cord-342324-it6zcyht	26	25	raloxifene	raloxifene	NNP
cord-342324-it6zcyht	26	26	,	,	,
cord-342324-it6zcyht	26	27	which	which	WDT
cord-342324-it6zcyht	26	28	is	be	VBZ
cord-342324-it6zcyht	26	29	also	also	RB
cord-342324-it6zcyht	26	30	associated	associate	VBN
cord-342324-it6zcyht	26	31	with	with	IN
cord-342324-it6zcyht	26	32	such	such	JJ
cord-342324-it6zcyht	26	33	risk	risk	NN
cord-342324-it6zcyht	26	34	(	(	-LRB-
cord-342324-it6zcyht	26	35	8)	8)	NN
cord-342324-it6zcyht	26	36	.	.	.
cord-342324-it6zcyht	27	1	Finally	finally	RB
cord-342324-it6zcyht	27	2	,	,	,
cord-342324-it6zcyht	27	3	timing	time	VBG
cord-342324-it6zcyht	27	4	the	the	DT
cord-342324-it6zcyht	27	5	transition	transition	NN
cord-342324-it6zcyht	27	6	of	of	IN
cord-342324-it6zcyht	27	7	treatment	treatment	NN
cord-342324-it6zcyht	27	8	from	from	IN
cord-342324-it6zcyht	27	9	anabolic	anabolic	JJ
cord-342324-it6zcyht	27	10	(	(	-LRB-
cord-342324-it6zcyht	27	11	teriparatide	teriparatide	NNP
cord-342324-it6zcyht	27	12	,	,	,
cord-342324-it6zcyht	27	13	abaloparatide	abaloparatide	NNP
cord-342324-it6zcyht	27	14	,	,	,
cord-342324-it6zcyht	27	15	romosozumab	romosozumab	NNP
cord-342324-it6zcyht	27	16	)	)	-RRB-
cord-342324-it6zcyht	27	17	to	to	TO
cord-342324-it6zcyht	27	18	injectable	injectable	JJ
cord-342324-it6zcyht	27	19	antiresorptive	antiresorptive	JJ
cord-342324-it6zcyht	27	20	therapy	therapy	NN
cord-342324-it6zcyht	27	21	(	(	-LRB-
cord-342324-it6zcyht	27	22	zoledronic	zoledronic	NNP
cord-342324-it6zcyht	27	23	acid	acid	NNP
cord-342324-it6zcyht	27	24	,	,	,
cord-342324-it6zcyht	27	25	denosumab	denosumab	NNP
cord-342324-it6zcyht	27	26	)	)	-RRB-
cord-342324-it6zcyht	27	27	during	during	IN
cord-342324-it6zcyht	27	28	a	a	DT
cord-342324-it6zcyht	27	29	pandemic	pandemic	NN
cord-342324-it6zcyht	27	30	is	be	VBZ
cord-342324-it6zcyht	27	31	also	also	RB
cord-342324-it6zcyht	27	32	important	important	JJ
cord-342324-it6zcyht	27	33	.	.	.
cord-342324-it6zcyht	28	1	Admittedly	admittedly	RB
cord-342324-it6zcyht	28	2	,	,	,
cord-342324-it6zcyht	28	3	there	there	EX
cord-342324-it6zcyht	28	4	are	be	VBP
cord-342324-it6zcyht	28	5	no	no	DT
cord-342324-it6zcyht	28	6	guidelines	guideline	NNS
cord-342324-it6zcyht	28	7	or	or	CC
cord-342324-it6zcyht	28	8	consensus	consensus	NN
cord-342324-it6zcyht	28	9	on	on	IN
cord-342324-it6zcyht	28	10	how	how	WRB
cord-342324-it6zcyht	28	11	best	good	JJS
cord-342324-it6zcyht	28	12	to	to	TO
cord-342324-it6zcyht	28	13	achieve	achieve	VB
cord-342324-it6zcyht	28	14	these	these	DT
cord-342324-it6zcyht	28	15	transitions	transition	NNS
cord-342324-it6zcyht	28	16	,	,	,
cord-342324-it6zcyht	28	17	we	-PRON-	PRP
cord-342324-it6zcyht	28	18	recommend	recommend	VBP
cord-342324-it6zcyht	28	19	continuing	continue	VBG
cord-342324-it6zcyht	28	20	anabolic	anabolic	JJ
cord-342324-it6zcyht	28	21	therapies	therapy	NNS
cord-342324-it6zcyht	28	22	for	for	IN
cord-342324-it6zcyht	28	23	additional	additional	JJ
cord-342324-it6zcyht	28	24	1	1	CD
cord-342324-it6zcyht	28	25	-	-	SYM
cord-342324-it6zcyht	28	26	2	2	CD
cord-342324-it6zcyht	28	27	months	month	NNS
cord-342324-it6zcyht	28	28	.	.	.
cord-342324-it6zcyht	29	1	If	if	IN
cord-342324-it6zcyht	29	2	the	the	DT
cord-342324-it6zcyht	29	3	transition	transition	NN
cord-342324-it6zcyht	29	4	must	must	MD
cord-342324-it6zcyht	29	5	be	be	VB
cord-342324-it6zcyht	29	6	made	make	VBN
cord-342324-it6zcyht	29	7	,	,	,
cord-342324-it6zcyht	29	8	the	the	DT
cord-342324-it6zcyht	29	9	interval	interval	NN
cord-342324-it6zcyht	29	10	between	between	IN
cord-342324-it6zcyht	29	11	treatments	treatment	NNS
cord-342324-it6zcyht	29	12	should	should	MD
cord-342324-it6zcyht	29	13	not	not	RB
cord-342324-it6zcyht	29	14	exceed	exceed	VB
cord-342324-it6zcyht	29	15	2	2	CD
cord-342324-it6zcyht	29	16	-	-	SYM
cord-342324-it6zcyht	29	17	4	4	CD
cord-342324-it6zcyht	29	18	weeks	week	NNS
cord-342324-it6zcyht	29	19	because	because	IN
cord-342324-it6zcyht	29	20	of	of	IN
cord-342324-it6zcyht	29	21	concerns	concern	NNS
cord-342324-it6zcyht	29	22	related	relate	VBN
cord-342324-it6zcyht	29	23	to	to	IN
cord-342324-it6zcyht	29	24	rapid	rapid	JJ
cord-342324-it6zcyht	29	25	and	and	CC
cord-342324-it6zcyht	29	26	substantial	substantial	JJ
cord-342324-it6zcyht	29	27	decline	decline	NN
cord-342324-it6zcyht	29	28	in	in	IN
cord-342324-it6zcyht	29	29	bone	bone	NN
cord-342324-it6zcyht	29	30	density	density	NN
cord-342324-it6zcyht	29	31	.	.	.
cord-342324-it6zcyht	30	1	In	in	IN
cord-342324-it6zcyht	30	2	patients	patient	NNS
cord-342324-it6zcyht	30	3	on	on	IN
cord-342324-it6zcyht	30	4	monthly	monthly	JJ
cord-342324-it6zcyht	30	5	romosozumab	romosozumab	NNS
cord-342324-it6zcyht	30	6	,	,	,
cord-342324-it6zcyht	30	7	the	the	DT
cord-342324-it6zcyht	30	8	scheduled	scheduled	JJ
cord-342324-it6zcyht	30	9	dose	dose	NN
cord-342324-it6zcyht	30	10	can	can	MD
cord-342324-it6zcyht	30	11	be	be	VB
cord-342324-it6zcyht	30	12	delayed	delay	VBN
cord-342324-it6zcyht	30	13	for	for	IN
cord-342324-it6zcyht	30	14	1	1	CD
cord-342324-it6zcyht	30	15	-	-	SYM
cord-342324-it6zcyht	30	16	2	2	CD
cord-342324-it6zcyht	30	17	months	month	NNS
cord-342324-it6zcyht	30	18	.	.	.
cord-342324-it6zcyht	31	1	These	these	DT
cord-342324-it6zcyht	31	2	potential	potential	JJ
cord-342324-it6zcyht	31	3	approaches	approach	NNS
cord-342324-it6zcyht	31	4	may	may	MD
cord-342324-it6zcyht	31	5	vary	vary	VB
cord-342324-it6zcyht	31	6	among	among	IN
cord-342324-it6zcyht	31	7	local	local	JJ
cord-342324-it6zcyht	31	8	practices	practice	NNS
cord-342324-it6zcyht	31	9	depending	depend	VBG
cord-342324-it6zcyht	31	10	on	on	IN
cord-342324-it6zcyht	31	11	available	available	JJ
cord-342324-it6zcyht	31	12	resources	resource	NNS
cord-342324-it6zcyht	31	13	and	and	CC
cord-342324-it6zcyht	31	14	infrastructure	infrastructure	NN
cord-342324-it6zcyht	31	15	.	.	.
cord-342324-it6zcyht	32	1	Our	-PRON-	PRP$
cord-342324-it6zcyht	32	2	Response	response	NN
cord-342324-it6zcyht	32	3	to	to	TO
cord-342324-it6zcyht	32	4	COVID-19	covid-19	VB
cord-342324-it6zcyht	32	5	as	as	IN
cord-342324-it6zcyht	32	6	Inpatient	Inpatient	NNP
cord-342324-it6zcyht	32	7	Use	Use	NNP
cord-342324-it6zcyht	32	8	of	of	IN
cord-342324-it6zcyht	32	9	Ambulatory	Ambulatory	NNP
cord-342324-it6zcyht	32	10	Telemetry	Telemetry	NNP
cord-342324-it6zcyht	32	11	Monitors	Monitors	NNPS
cord-342324-it6zcyht	32	12	for	for	IN
cord-342324-it6zcyht	32	13	COVID-19	COVID-19	NNP
cord-342324-it6zcyht	32	14	Patients	Patients	NNPS
cord-342324-it6zcyht	32	15	Treated	treat	VBN
cord-342324-it6zcyht	32	16	with	with	IN
cord-342324-it6zcyht	32	17	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-342324-it6zcyht	32	18	and/or	and/or	CC
cord-342324-it6zcyht	32	19	Azithromycin	Azithromycin	NNP
cord-342324-it6zcyht	32	20	Electrolyte	Electrolyte	NNP
cord-342324-it6zcyht	32	21	screening	screening	NN
cord-342324-it6zcyht	32	22	in	in	IN
cord-342324-it6zcyht	32	23	the	the	DT
cord-342324-it6zcyht	32	24	evaluation	evaluation	NN
cord-342324-it6zcyht	32	25	of	of	IN
cord-342324-it6zcyht	32	26	prolonged	prolonged	JJ
cord-342324-it6zcyht	32	27	QTc	QTc	NNP
cord-342324-it6zcyht	32	28	interval	interval	NN
cord-342324-it6zcyht	33	1	Do	do	VBP
cord-342324-it6zcyht	33	2	we	-PRON-	PRP
cord-342324-it6zcyht	33	3	need	need	VB
cord-342324-it6zcyht	33	4	sick	sick	JJ
cord-342324-it6zcyht	33	5	-	-	HYPH
cord-342324-it6zcyht	33	6	day	day	NN
cord-342324-it6zcyht	33	7	guidelines	guideline	NNS
cord-342324-it6zcyht	33	8	for	for	IN
cord-342324-it6zcyht	33	9	hypoparathyroidism	hypoparathyroidism	NNP
cord-342324-it6zcyht	33	10	Severe	Severe	NNP
cord-342324-it6zcyht	33	11	Rebound	Rebound	NNP
cord-342324-it6zcyht	33	12	-	-	HYPH
cord-342324-it6zcyht	33	13	Associated	Associated	NNP
cord-342324-it6zcyht	33	14	Vertebral	Vertebral	NNP
cord-342324-it6zcyht	33	15	Fractures	fracture	NNS
cord-342324-it6zcyht	33	16	After	after	IN
cord-342324-it6zcyht	33	17	Denosumab	Denosumab	NNP
cord-342324-it6zcyht	33	18	Discontinuation	discontinuation	NN
cord-342324-it6zcyht	33	19	:	:	:
cord-342324-it6zcyht	33	20	9	9	CD
cord-342324-it6zcyht	33	21	Clinical	Clinical	NNP
cord-342324-it6zcyht	33	22	Cases	Cases	NNPS
cord-342324-it6zcyht	33	23	Report	Report	NNP
cord-342324-it6zcyht	33	24	Letter	Letter	NNP
cord-342324-it6zcyht	33	25	to	to	IN
cord-342324-it6zcyht	33	26	the	the	DT
cord-342324-it6zcyht	33	27	Editor	editor	NN
cord-342324-it6zcyht	33	28	:	:	:
cord-342324-it6zcyht	34	1	Severe	severe	JJ
cord-342324-it6zcyht	34	2	Rebound	rebound	NN
cord-342324-it6zcyht	34	3	-	-	HYPH
cord-342324-it6zcyht	34	4	Associated	Associated	NNP
cord-342324-it6zcyht	34	5	Vertebral	Vertebral	NNP
cord-342324-it6zcyht	34	6	Fractures	fracture	NNS
cord-342324-it6zcyht	34	7	After	after	IN
cord-342324-it6zcyht	34	8	Denosumab	Denosumab	NNP
cord-342324-it6zcyht	34	9	Discontinuation	discontinuation	VBP
cord-342324-it6zcyht	34	10	Cardiovascular	cardiovascular	JJ
cord-342324-it6zcyht	34	11	complications	complication	NNS
cord-342324-it6zcyht	34	12	in	in	IN
cord-342324-it6zcyht	34	13	COVID-19	COVID-19	NNP
cord-342324-it6zcyht	34	14	The	the	DT
cord-342324-it6zcyht	34	15	Beneficial	beneficial	JJ
cord-342324-it6zcyht	34	16	and	and	CC
cord-342324-it6zcyht	34	17	Adverse	adverse	JJ
cord-342324-it6zcyht	34	18	Effects	effect	NNS
cord-342324-it6zcyht	34	19	of	of	IN
cord-342324-it6zcyht	34	20	Raloxifene	Raloxifene	NNP
cord-342324-it6zcyht	34	21	in	in	IN
cord-342324-it6zcyht	34	22	Menopausal	Menopausal	NNP
cord-342324-it6zcyht	34	23	Women	Women	NNPS
cord-342324-it6zcyht	34	24	:	:	:
cord-342324-it6zcyht	35	1	A	a	DT
cord-342324-it6zcyht	35	2	Mini	Mini	NNP
cord-342324-it6zcyht	35	3	Review	Review	NNP
cord-342324-it6zcyht	35	4	A	a	NN
cord-342324-it6zcyht	36	1	c	c	NNP
cord-342324-it6zcyht	36	2	c	c	NNP
cord-342324-it6zcyht	36	3	e	e	NN
cord-342324-it6zcyht	36	4	p	p	NN
cord-342324-it6zcyht	36	5	t	t	NN
cord-342324-it6zcyht	36	6	e	e	NN
cord-342324-it6zcyht	36	7	d	d	NNP
cord-342324-it6zcyht	36	8	M	M	NNP
cord-342324-it6zcyht	36	9	a	a	NNP
cord-342324-it6zcyht	37	1	n	n	CC
cord-342324-it6zcyht	37	2	u	u	NNP
cord-342324-it6zcyht	37	3	s	s	NNP
cord-342324-it6zcyht	37	4	c	c	NN
cord-342324-it6zcyht	37	5	r	r	NN
cord-342324-it6zcyht	38	1	i	i	NN
cord-342324-it6zcyht	38	2	p	p	NN
cord-342324-it6zcyht	38	3	t	t	NN